NCT01580072 .

Methods	Study design: unknown centres; open‐label, parallel individual randomised controlled trial in Austria Duration: 52 weeks Setting: unknown
Participants	Population: 65 adults recruited from Carinthia, Austria Baseline characteristics: unknown Inclusion criteria: III/IV GOLD COPD, life expectancy > 12 months, able to use system Exclusion criteria: unknown
Interventions	Measurements taken at baseline and at 12 months Treatment arms Mobile phone device use for telemonitoring data to a Web Portal or automatic call centre for self‐monitoring and nurse monitoring
Outcomes	Primary outcomes: QOL SF‐36, inpatient stays Secondary outcomes: number of bed days for hospitalised patients, number of PC visits, number of specialist visits, number of emergency department visits, mortality, CAT, SGRQ
Notes	Funding: Ladeskrankenanstalten‐Betriebsgesellschaft Other identifier: NCT01580072; C250487